BCDA BioCardia, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 12, 2026
$1,04
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,7552 haftanın en düşüğü
$1,8052 haftanın en yükseği
Piyasa Değeri (MRQ)
$16M
Gelir
$0
rozetleriniz
52 Haftlık Aralık
$1–$2
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$16
P/E
·
ROE
1660.5%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
BCDA Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.04
Piyasa Değeri (MRQ)
$16M
Gelir
$0
ROE
1660.5%
52 Haftlık Aralık
$1–$2
BCDA Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 30 Mayıs 2024 | 1-for-15 | Ters |
| 06 Haziran 2019 | 1-for-9 | Ters |
| 03 Kasım 2017 | 1-for-12 | Ters |
| 14 Mart 2008 | 1-for-10 | Ters |
| 06 Ocak 2004 | 6-for-1 | İleri |
| 23 Ağustos 2001 | 1-for-3 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$02016-12-31 → 2025-12-31
Serbest Nakit Akışı$-7M2017-12-31 → 2025-12-31
Net kar marjı·2017-12-31 → 2024-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | BCDA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| F/D (MRQ) | 5.85Y ort. ≈-18.0 | ≈-18.0 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -2.15Y ort. ≈-18.3 | ≈-18.3 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -2.15Y ort. ≈-18.5 | ≈-18.5 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 12.55Y ort. ≈50.7 | ≈50.7 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | BCDA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -230.6%5Y ort. ≈-178.2% | ≈-178.2% | · | · | |
| ROE | 1660.5%5Y ort. ≈533.6% | ≈533.6% | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | BCDA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 2.15Y ort. ≈1.6 | ≈1.6 | 1.3 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 1.05Y ort. ≈1.5 | ≈1.5 | 1.1 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | BCDA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -87.8%5Y ort. ≈120.2% | ≈120.2% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -61.5% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | BCDA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.05Y ort. ≈0.0 | ≈0.0 | · | · | |
| Receivables Turnover (Alacak Devir Hızı) | 0.05Y ort. ≈2.7 | ≈2.7 | · | · | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$0.00 | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
14.5%
Sonraki Rapor
Kas 10, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 12, 2026 | $-0.13 | $-0.18 | 29.2% |
| 31 Mart 2026 | May 15, 2026 | $-0.21 | $-0.17 | -24.8% |
| 31 Aralık 2025 | $-0.06 | $-0.17 | 65.4% | |
| 30 Eylül 2025 | $-0.24 | $-0.23 | -2.3% | |
| 30 Haziran 2025 | $-0.40 | $-0.51 | 21.6% | |
| 31 Mart 2025 | $-0.59 | $-0.40 | -48.3% | |
| 31 Aralık 2024 | $-0.25 | $-0.64 | 60.8% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $58.0K | $477.0K | $1M | $1M | $145.0K | $710.0K | $625.0K | $479.0K | $576.0K | $904.0K | · | |
| Cost of Revenue | · | · | · | · | $0 | $4.0K | $358.0K | $517.0K | $690.0K | $746.0K | $1M | · | |
| R&D Expense | $5M | $4M | $8M | $9M | $9M | $10M | $9M | $8M | $6M | $3M | $2M | · | |
| SG&A Expense | $3M | $4M | $4M | $4M | $5M | $6M | $6M | $6M | $6M | $4M | $4M | $196.0K | |
| Operating Expenses | $8M | $8M | $12M | $13M | $14M | $16M | $15M | $15M | $13M | $8M | $6M | · | |
| Operating Income | $-8M | $-8M | $-12M | $-12M | $-13M | $-16M | $-14M | $-14M | $-12M | $-8M | $-5M | $231.0K | |
| Interest Expense | · | · | · | · | $0 | $3.0K | $112.0K | · | · | $2M | $1M | · | |
| Interest Income | · | · | · | · | $9.0K | $21.0K | · | · | · | · | · | · | |
| Other Non-op | $50.0K | $55.0K | $73.0K | $-6.0K | $7.0K | $-2.0K | $-2.0K | $-3.0K | $2.0K | $-2.0K | $-2.0K | · | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $322.0K | $234.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-8M | $-8M | $-12M | $-12M | $-13M | $-15M | $-15M | $-14M | $-12M | $-10M | $-7M | $234.0K | |
| EPS (Basic) | $-1.23 | $-2.90 | $-8.19 | $-0.67 | $-0.75 | · | · | · | · | · | · | · | |
| Shares (Basic) | 6,666,943 | 2,743,828 | 1,411,998 | 17,720,972 | 16,917,664 | · | · | · | · | · | · | · | |
| Shares (Diluted) | · | · | · | · | · | · | · | · | · | · | 230,293,141 | 230,293,141 | |
| EBITDA | $-8M | $-8M | $-12M | · | $-13M | $-15M | $-14M | $-14M | $-12M | · | $319.0K | $231.0K |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $2M | $1M | $7M | $13M | $21M | $6M | $5M | $13M | $21M | $4M | $3M | |
| Receivables | $20.0K | $0 | $63.0K | $201.0K | $147.0K | $232.0K | $147.0K | $274.0K | $95.0K | $74.0K | $107.0K | · | |
| Inventory | · | · | · | · | · | · | $4.0K | $141.0K | $191.0K | $135.0K | $759.0K | · | |
| Prepaid Expense | $216.0K | $251.0K | $295.0K | $300.0K | $462.0K | $401.0K | · | $445.0K | $340.0K | $356.0K | $146.0K | $36.0K | |
| Current Assets | $3M | $3M | $1M | $8M | $13M | $23M | $6M | $6M | $13M | $22M | $5M | · | |
| PP&E (Net) | $16.0K | $33.0K | $94.0K | $170.0K | $182.0K | $145.0K | $181.0K | $145.0K | $169.0K | $111.0K | $150.0K | · | |
| PP&E (Gross) | $801.0K | $794.0K | $788.0K | $789.0K | $719.0K | $1M | $1M | $990.0K | $927.0K | $882.0K | $882.0K | · | |
| Accum. Depreciation | $785.0K | $761.0K | $694.0K | $619.0K | $537.0K | $1M | $957.0K | $845.0K | $758.0K | $771.0K | $732.0K | · | |
| Other Non-current Assets | $171.0K | $171.0K | $171.0K | $171.0K | $172.0K | $54.0K | $54.0K | $54.0K | $54.0K | $54.0K | $43.0K | · | |
| Total Assets | $3M | $4M | $3M | $10M | $16M | $23M | $8M | $6M | $14M | $22M | $5M | $14M | |
| Accounts Payable | $641.0K | $385.0K | $890.0K | $683.0K | $507.0K | $746.0K | $914.0K | $743.0K | $902.0K | $525.0K | $542.0K | $10.0K | |
| Accrued Liabilities | $34.0K | $22.0K | $75.0K | $157.0K | $240.0K | $87.0K | $10.0K | $127.0K | $465.0K | $478.0K | $692.0K | · | |
| Current Liabilities | $2M | $2M | $4M | $4M | $4M | $4M | $4M | $3M | $2M | $1M | $8M | · | |
| Capital Leases | $86.0K | $566.0K | $982.0K | $1M | $2M | $0 | $614.0K | · | · | · | · | · | |
| Total Liabilities | $3M | $3M | $5M | $5M | $5M | $4M | $5M | $3M | $2M | $2M | $8M | $10.0K | |
| Common Stock | $11.0K | $5.0K | $2.0K | $20.0K | $17.0K | $16.0K | $7.0K | $5.0K | $38.0K | $38.0K | $19.0K | $230.0K | |
| Paid-in Capital | $169M | $161M | $151M | $145M | $139M | $135M | $103M | $90M | $84M | $81M | $341.0K | $26M | |
| Retained Earnings | $-168M | $-160M | $-152M | $-141M | $-129M | $-116M | $-101M | $-86M | $-72M | $-60M | $-50M | $-12M | |
| Stockholders' Equity | $895.0K | $837.0K | $-2M | $5M | $10M | $19M | $2M | $4M | $11M | $21M | $-3M | $-43M | |
| Liabilities + Equity | $3M | $4M | $3M | $10M | $16M | $23M | $8M | $6M | $14M | $22M | $5M | $14M | |
| Shares Outstanding | 10,755,647 | 4,600,910 | 1,577,769 | 20,076,773 | 16,871,265 | 16,297,381 | 6,825,183 | 4,845,697 | 38,218,660 | 38,131,303 | 18,947,536 | 230,293,141 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $24.0K | $67.0K | $84.0K | $82.0K | $60.0K | $68.0K | $111.0K | $88.0K | $78.0K | $39.0K | $47.0K | · | |
| Stock-based Comp | $430.0K | $741.0K | $1M | $1M | $2M | $3M | $3M | $3M | $3M | $942.0K | $283.0K | $0 | |
| Other Non-cash | $338.0K | $-888.0K | $483.0K | · | $536.0K | $-373.0K | $2M | $56.0K | $852.0K | · | · | · | |
| Operating Cash Flow | $-7M | $-8M | $-10M | $-11M | $-10M | $-12M | $-9M | $-11M | $-9M | $-6M | $-7M | $214.0K | |
| CapEx | $7.0K | $6.0K | $12.0K | $70.0K | $116.0K | $32.0K | $146.0K | $66.0K | $136.0K | · | $125.0K | · | |
| Investing Cash Flow | $-7.0K | $-6.0K | $-12.0K | $-70.0K | $-116.0K | $-32.0K | $-146.0K | $-66.0K | $-136.0K | $19M | $-125.0K | · | |
| Stock Issued | $9M | $11M | $4M | $6M | $2M | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $9M | $11M | $4M | · | $2M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $8M | $9M | $4M | $5M | $2M | $28M | $10M | $4M | $144.0K | $4M | $8M | · | |
| Net Change in Cash | $125.0K | $1M | $-6M | $-6M | $-9M | $16M | $227.0K | · | · | · | $331.0K | $214.0K | |
| Free Cash Flow | $-7M | $-8M | $-10M | · | $-10M | $-12M | $-10M | $-11M | $-9M | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -13794.8% | -2441.1% | · | -1244.3% | -10709.7% | -2001.8% | -2256.3% | -2589.8% | · | · | · | |
| Net Margin | · | -13700.0% | -2425.8% | · | -1243.7% | -10347.6% | -2071.7% | -2237.9% | -2569.5% | · | · | · | |
| EBITDA Margin | · | -13679.3% | -2423.5% | · | -1238.4% | -10662.8% | -1986.2% | -2242.2% | -2573.5% | · | · | · | |
| ROA | -230.6% | -236.8% | -181.1% | · | -64.5% | -96.5% | -208.7% | -140.2% | -69.1% | · | 2.3% | 1.7% | |
| ROE | 1660.5% | -442.7% | 1022.6% | · | -106.1% | -128.8% | -388.9% | -415.3% | -77.6% | · | -2.2% | 1.7% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | 2.3% | 1.7% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | 0.4 | · | 3.6 | 5.3 | 1.6 | 2.4 | 5.7 | · | · | · | |
| Quick Ratio | 1.0 | 1.0 | 0.3 | · | 3.5 | 5.1 | 1.4 | 2.2 | 5.5 | · | · | · | |
| Interest Coverage | · | · | · | · | · | -5176.3 | -126.9 | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | · | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | · | · | · | |
| Inventory Turnover | · | · | · | · | · | · | 4.9 | 3.1 | 4.2 | · | · | · | |
| Receivables Turnover | 0.0 | 1.8 | 3.6 | · | 5.4 | 0.8 | 3.4 | 3.4 | 5.7 | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.08 | $0.18 | $-0.07 | · | $0.61 | $1.18 | $0.35 | $0.09 | $0.29 | · | $0.06 | $0.06 | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | · | $0.00 | $0.00 | |
| Cash / Share | $0.23 | $0.52 | $0.05 | · | $0.76 | $1.31 | $0.82 | $0.12 | $0.33 | · | $0.06 | $0.06 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | -87.8% | -64.7% | 33.2% | 600.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | -61.5% | 48.7% | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $58.0K | $477.0K | $1M | $1M | $145.0K | $710.0K | $625.0K | $479.0K | $576.0K | $904.0K | $47.0K | |
| Net Income TTM | $-8M | $-8M | $-12M | $-12M | $-13M | $-15M | $-15M | $-14M | $-12M | $-10M | $-7M | $234.0K | |
| Market Cap | $13M | $10M | $234M | · | $491M | $846M | $377M | $7.07B | $12.12B | · | $29.85B | $41.04B | |
| P/S | · | 172.9 | 491.2 | · | 483.7 | 5833.3 | 530.6 | 11304.0 | 25312.9 | · | 33015.5 | 873154.0 | |
| P/B | 15.0 | 12.0 | -146.2 | · | 47.3 | 44.1 | 159.0 | 1863.1 | 1089.9 | · | 2152.5 | 3030.0 | |
| P / Tangible Book | 15.0 | 12.0 | · | 128.7 | 47.3 | 44.1 | · | · | · | · | · | · | |
| P / Cash Flow | -1.8 | -1.2 | -23.5 | · | -47.4 | -68.4 | -39.9 | -638.3 | -1398.3 | · | 90169.2 | 191767.5 | |
| P / FCF | -1.8 | -1.2 | -23.5 | · | -46.8 | -68.3 | -39.3 | -634.5 | -1376.7 | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $3.0K | $55.0K | $13.0K | $357.0K | $43.0K | $64.0K | $106.0K | $212.0K | |
| R&D Expense | $893.0K | $1M | $1M | $936.0K | $1M | $2M | $1M | $931.0K | $800.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | |
| SG&A Expense | $730.0K | $1M | $885.0K | $552.0K | $683.0K | $1M | $906.0K | $825.0K | $852.0K | $1M | $941.0K | $1M | $1M | $1M | $924.0K | $1M | |
| Operating Expenses | $2M | $2M | $2M | $1M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $3M | $3M | |
| Operating Income | $-2M | $-2M | $-2M | $-1M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-3M | $-3M | |
| Other Non-op | $10.0K | $7.0K | $29.0K | $5.0K | $2.0K | $14.0K | $25.0K | $19.0K | $3.0K | $8.0K | $12.0K | $24.0K | $28.0K | $9.0K | $-10.0K | $3.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-2M | $-2M | $-2M | $-1M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-3M | $-3M | |
| EPS (Basic) | $-0.13 | $-0.21 | $0.00 | $-0.24 | $-0.40 | $-0.59 | $-0.06 | $-0.61 | $-0.88 | $-1.35 | $-3.71 | $-1.79 | $-2.52 | $-0.17 | $-0.17 | $-0.17 | |
| EPS (Diluted) | · | $-0.21 | · | · | $-0.40 | $-0.59 | · | · | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 12,093,268 | 10,812,419 | · | 6,277,848 | 5,059,736 | 4,635,764 | · | 2,827,492 | 1,877,069 | 1,675,539 | · | 1,441,043 | 1,358,968 | 20,177,167 | · | 17,844,991 | |
| Shares (Diluted) | · | 10,812,419 | · | · | 5,059,736 | 4,635,764 | · | · | · | · | · | · | · | · | · | · | |
| EBITDA | $-2M | $-2M | · | $-1M | $-2M | $-3M | · | $-2M | $-2M | $-2M | · | $-3M | $-3M | $-3M | · | $-3M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $951.0K | $2M | $5M | $980.0K | $949.0K | $2M | $5M | $1M | $949.0K | $1M | $2M | $4M | $5M | $7M | $7M | |
| Receivables | $30.0K | $20.0K | $20.0K | · | $10.0K | · | $0 | $10.0K | $10.0K | $58.0K | $63.0K | $104.0K | $115.0K | $153.0K | $201.0K | $300.0K | |
| Prepaid Expense | $151.0K | $169.0K | $216.0K | $78.0K | $209.0K | $224.0K | $251.0K | $116.0K | $142.0K | $252.0K | $295.0K | $177.0K | $230.0K | $279.0K | $300.0K | $187.0K | |
| Current Assets | $4M | $1M | $3M | $5M | $1M | $1M | $3M | $5M | $2M | $1M | $1M | $2M | $5M | $5M | $8M | $7M | |
| PP&E (Net) | $13.0K | $16.0K | $16.0K | $13.0K | $17.0K | $21.0K | $33.0K | $47.0K | $61.0K | $75.0K | $94.0K | $114.0K | $139.0K | $158.0K | $170.0K | $189.0K | |
| PP&E (Gross) | $804.0K | $804.0K | $801.0K | $795.0K | $795.0K | $794.0K | $794.0K | $793.0K | $791.0K | $788.0K | $788.0K | $788.0K | $801.0K | $799.0K | $789.0K | $787.0K | |
| Accum. Depreciation | $791.0K | $788.0K | $785.0K | $782.0K | $778.0K | $773.0K | $761.0K | $746.0K | $730.0K | $713.0K | $694.0K | $674.0K | $662.0K | $641.0K | $619.0K | $598.0K | |
| Other Non-current Assets | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $172.0K | $171.0K | $172.0K | |
| Total Assets | $5M | $2M | $3M | $6M | $2M | $2M | $4M | $6M | $3M | $3M | $3M | $4M | $6M | $7M | $10M | $9M | |
| Accounts Payable | $541.0K | $820.0K | $641.0K | $1M | $1M | $818.0K | $385.0K | $569.0K | $1M | $1M | $890.0K | $507.0K | $686.0K | $861.0K | $683.0K | $887.0K | |
| Accrued Liabilities | $30.0K | $52.0K | $34.0K | $108.0K | $41.0K | $243.0K | $22.0K | $28.0K | $4.0K | $116.0K | $75.0K | $36.0K | $111.0K | $38.0K | $157.0K | $115.0K | |
| Current Liabilities | $2M | $3M | $2M | $3M | $4M | $3M | $2M | $3M | $4M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | |
| Capital Leases | $0 | $0 | $86.0K | $211.0K | $333.0K | $452.0K | $566.0K | $674.0K | $780.0K | $883.0K | $982.0K | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $2M | $3M | $3M | $4M | $4M | $4M | $3M | $4M | $5M | $5M | $5M | $4M | $5M | $5M | $5M | $5M | |
| Common Stock | $15.0K | $11.0K | $11.0K | $11.0K | $6.0K | $5.0K | $5.0K | $5.0K | $2.0K | $27.0K | $2.0K | $22.0K | $22.0K | $20.0K | $20.0K | $18.0K | |
| Paid-in Capital | $175M | $170M | $169M | $169M | $163M | $161M | $161M | $161M | $154M | $152M | $151M | $149M | $149M | $146M | $145M | $142M | |
| Retained Earnings | $-172M | $-171M | $-168M | $-166M | $-165M | $-163M | $-160M | $-158M | $-156M | $-154M | $-152M | $-150M | $-148M | $-144M | $-141M | $-138M | |
| Stockholders' Equity | $3M | $-1M | $895.0K | $3M | $-2M | $-2M | $837.0K | $3M | $-2M | $-2M | $-2M | $-660.0K | $2M | $2M | $5M | $4M | |
| Liabilities + Equity | $5M | $2M | $3M | $6M | $2M | $2M | $4M | $6M | $3M | $3M | $3M | $4M | $6M | $7M | $10M | $9M | |
| Shares Outstanding | 14,984,323 | 10,940,372 | 10,755,647 | 10,608,734 | 5,504,802 | 4,682,184 | 4,600,910 | 4,523,876 | 2,123,876 | 26,836,389 | · | 21,619,432 | 21,586,150 | 20,202,005 | · | 17,841,927 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3.0K | $3.0K | $3.0K | $4.0K | $5.0K | $12.0K | $15.0K | $16.0K | $17.0K | $19.0K | $20.0K | $21.0K | $21.0K | $22.0K | $21.0K | $29.0K | |
| Stock-based Comp | $109.0K | $113.0K | $85.0K | $77.0K | $98.0K | $170.0K | $176.0K | $177.0K | $184.0K | $204.0K | $184.0K | $251.0K | $317.0K | $278.0K | $280.0K | $280.0K | |
| Other Non-cash | · | $484.0K | · | · | · | $912.0K | · | · | · | $514.0K | · | · | · | $641.0K | · | · | |
| Operating Cash Flow | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-1M | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M | $-2M | |
| CapEx | $0 | $3.0K | $6.0K | $0 | $1.0K | $0 | $1.0K | $2.0K | $3.0K | $0 | $0 | $0 | $2.0K | $10.0K | $2.0K | $14.0K | |
| Investing Cash Flow | $0 | $-3.0K | $-6.0K | $0 | $-1.0K | $0 | $-1.0K | $-2.0K | $-3.0K | $0 | $0 | $0 | $-2.0K | $-10.0K | $-2.0K | $-14.0K | |
| Stock Issued | $5M | $225.0K | $0 | $7M | $2M | $212.0K | $39.0K | $7M | $2M | $1M | $1M | $92.0K | $3M | $244.0K | $4M | $139.0K | |
| Net Stock Activity | · | $225.0K | · | · | · | $212.0K | · | · | · | $1M | · | · | · | $244.0K | · | · | |
| Financing Cash Flow | $5M | $117.0K | $-288.0K | $6M | $2M | $196.0K | $-125.0K | $6M | $2M | $1M | $1M | $-58.0K | $3M | $64.0K | $4M | $73.0K | |
| Net Change in Cash | $3M | $-2M | $-3M | $4M | $31.0K | $-1M | $-3M | $4M | $472.0K | $-154.0K | $-732.0K | $-2M | $-552.0K | $-3M | $696.0K | $-2M | |
| Free Cash Flow | · | $-2M | · | · | · | · | · | · | · | $-2M | · | · | · | $-3M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -54966.7% | -4136.4% | · | -727.7% | -8027.9% | -5484.4% | · | -1443.4% | |
| Net Margin | · | · | · | · | · | · | · | · | -54866.7% | -4121.8% | · | -721.0% | -7962.8% | -5470.3% | · | -1442.0% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -54966.7% | -4101.8% | · | -727.7% | -8027.9% | -5450.0% | · | -1443.4% | |
| ROA | -47.1% | -116.5% | · | -23.9% | -82.3% | -111.9% | · | -34.7% | -35.5% | -46.2% | · | -39.8% | -38.8% | -35.1% | · | -23.1% | |
| ROE | -396.3% | 174.7% | · | -55.1% | 106.5% | 142.9% | · | -166.0% | 1009.8% | 1209.1% | · | -149.8% | -81.8% | -75.5% | · | -34.9% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 0.4 | · | 1.6 | 0.3 | 0.4 | · | 1.8 | 0.4 | 0.3 | · | 0.6 | 1.3 | 1.3 | · | 1.9 | |
| Quick Ratio | 2.0 | 0.3 | · | 1.6 | 0.3 | 0.3 | · | 1.7 | 0.4 | 0.2 | · | 0.6 | 1.2 | 1.3 | · | 1.9 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | 0.0 | · | · | 0.0 | 0.0 | 0.5 | · | 1.8 | 0.3 | 0.3 | · | 0.9 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.18 | $-0.10 | · | $0.25 | $-0.34 | $-0.32 | · | $0.61 | $-0.92 | $-0.08 | · | $-0.03 | $0.08 | $0.09 | · | $0.23 | |
| Cash Flow / Share | · | $-0.15 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.27 | $0.09 | · | $0.50 | $0.18 | $0.20 | · | $1.09 | $0.67 | $0.04 | · | $0.08 | $0.20 | $0.24 | · | $0.37 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $3.0K | · | $71.0K | $428.0K | $468.0K | · | $570.0K | $425.0K | $1M | · | $1M | |
| Net Income TTM | $-7M | $-8M | · | $-9M | $-9M | $-8M | · | $-8M | $-9M | $-10M | · | $-13M | $-13M | $-12M | · | $-12M | |
| Market Cap | $19M | $13M | · | $14M | $11M | $12M | · | $14M | $6M | $165M | · | $139M | $865M | $591M | · | $519M | |
| P/S | · | · | · | · | · | 3964.2 | · | 198.8 | 14.7 | 352.7 | · | 244.6 | 2034.2 | 435.8 | · | 391.8 | |
| P/B | 6.9 | -12.4 | · | 5.2 | -5.7 | -7.8 | · | 5.1 | -3.2 | -72.5 | · | -211.3 | 528.8 | 311.0 | · | 126.7 | |
| P / Tangible Book | 6.9 | · | · | 5.2 | · | · | · | 5.1 | · | · | · | · | 528.8 | 311.0 | · | 126.7 | |
| P / Cash Flow | · | -8.0 | · | · | · | -7.4 | · | · | · | -107.9 | · | · | · | -230.8 | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $0 | $58.0K | $477.0K | $1M | $1M |
| Faaliyet Kâr Marjı % | · | -13794.8% | -2441.1% | · | -1244.3% |
| Net Gelir | $-8M | $-8M | $-12M | $-12M | $-13M |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 1.1 | 1.1 | 0.4 | · | 3.6 |
| Cari Oran | 1.0 | 1.0 | 0.3 | · | 3.5 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-7M | $-8M | $-10M | · | $-10M |
Kurumsal Sahipler (13F) 21 dosya · $1.8M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
21
Tutulan Değer
$1.8M
Yeni pozisyonlar
6
Çıkan pozisyonlar
5
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 6 (0 önceki Ç'ye göre) | 5 (+1 önceki Ç'ye göre) | 4 (-1 önceki Ç'ye göre) | 3 (+1 önceki Ç'ye göre) | +645K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| CITIGROUP INC | $493.017 | 397.594 | 27,40% | Hisse senetleri |
| CM Management, LLC | $372.000 | 300.000 | 20,68% | Hisse senetleri |
| VANGUARD GROUP INC | $169.452 | 135.561 | 9,42% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $154.493 | 124.591 | 8,59% | Hisse senetleri |
| Pingora Partners LLC | $149.274 | 120.382 | 8,30% | Hisse senetleri |
| UBS Group AG | $96.248 | 77.619 | 5,35% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $82.662 | 66.664 | 4,59% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $82.175 | 66.270 | 4,57% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48.123 | 38.809 | 2,67% | Hisse senetleri |
| BROWN ADVISORY INC | $44.067 | 35.538 | 2,45% | Hisse senetleri |
| COMMONWEALTH EQUITY SERVICES, LLC | $28.990 | 23.383 | 1,61% | Hisse senetleri |
| CITADEL ADVISORS LLC | $28.465 | 22.956 | 1,58% | Hisse senetleri |
| StoneX Group Inc. | $24.825 | 20.020 | 1,38% | Hisse senetleri |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $16.924 | 18.500 | 0,94% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $3.952 | 3.187 | 0,22% | Hisse senetleri |
| MORGAN STANLEY | $3.850 | 3.105 | 0,21% | Hisse senetleri |
| Global Retirement Partners, LLC | $510 | 411 | 0,03% | Hisse senetleri |
| GSA CAPITAL PARTNERS LLP | $16 | 12.862 | 0,00% | Hisse senetleri |
| SBI Securities Co., Ltd. | $11 | 9 | 0,00% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $1 | 1 | 0,00% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $1 | 1 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 26 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Blank Andrew Scott | 22 Mayıs 2025 | 5,50% | İlk başvuru | Yönetim kurulu kampanyası | SEC |
| Daly Joseph Patrick | 21 Mayıs 2025 | 0,00% | Değişiklik | · | SEC |
| Phillip Frost, M.D., Frost Gamma Investments Trust ×13 başvurular | 05 Nisan 2024 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 25 Mayıs 2023 | · | İlk başvuru | Pasif yatırım | SEC |
| Jim L. Allen ×2 başvurular | 09 Ocak 2023 | · | İlk başvuru | Pasif yatırım | SEC |
| Simon H. Stertzer (2), Kimberly Stertzer (2), Stertzer Family Trust (2), Windrock Enterprises L.L.C. (2) ×4 başvurular | 09 Ocak 2023 | · | İlk başvuru | · | SEC |
| Roumell Asset Management, LLC ("RAM"), James C. Roumell (Roumell) ×2 başvurular | 07 Şubat 2022 | · | İlk başvuru | Pasif yatırım | SEC |
| OPKO Health, Inc. ×2 başvurular | 23 Ekim 2019 | · | İlk başvuru | · | SEC |
| Andrew A. Brooks, M.D. ×4 başvurular | 19 Mayıs 2016 | · | İlk başvuru | · | SEC |
| Jonathan Brooks ×3 başvurular | 18 Mayıs 2016 | · | İlk başvuru | · | SEC |
| Mikhail Kvitnitsky ×2 başvurular | 05 Temmuz 2011 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 24 Mart 2008 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 24 Mart 2008 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 19 Mart 2008 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 19 Mart 2008 | · | İlk başvuru | · | SEC |
| Dr. Jane Hsiao, Ph. D. | 18 Mart 2008 | · | İlk başvuru | Pasif yatırım | SEC |
| Glenn L. Halpryn | 15 Ocak 2008 | · | İlk başvuru | Pasif yatırım | SEC |
| Steven Jerry Glauser, Steven Jerry Glauser Revocable Trust IRS ID | 15 Ocak 2008 | · | İlk başvuru | Pasif yatırım | SEC |
| Stephen Bittel | 15 Ocak 2008 | · | İlk başvuru | Pasif yatırım | SEC |
| Ernest M. Halpryn | 15 Ocak 2008 | · | İlk başvuru | Pasif yatırım | SEC |
| Roy Israel S.S. or, Carla Israel S.S. or | 28 Eylül 2007 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 15 Nisan 2005 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 18 Ocak 2005 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 12 Mart 2004 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 17 Mart 2003 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 20 Kasım 2001 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 38 içeriden öğrenenler · 10 yöneticiler · 22 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Peter Altman | President and CEO | 29 Eylül 2026 P | 384.885 | 30 | 0 | $65.582 |
| Steven D Rubin | Interim CEO and Interim CFO | 11 Ağustos 2016 A | 302.822 | 0 | 0 | $0 |
| Andrew A Brooks | CEO | 10 Mayıs 2016 S | 0 | 0 | 0 | $0 |
| Glenn L Halpryn | CEO | 29 Ağustos 2008 J | 533.312 | 0 | 0 | $0 |
| Roy Israel | Chairman,CEO & President | 26 Eylül 2007 S | 0 | 0 | 0 | $0 |
| David Mcclung | Chief Financial Officer | 06 Temmuz 2026 A | 114.245 | 0 | 0 | $0 |
| Edward M Gillis | Senior Vice President, Devices | 06 Temmuz 2026 A | 54.126 | 0 | 0 | $0 |
| Eric Duckers | Chief Medical Officer | 02 Kasım 2020 S | 12.088 | 0 | 0 | $0 |
| Phil Pesta | Vice President of Operations | 30 Haziran 2020 F | 11.867 | 0 | 0 | $0 |
| Richard T Allen | Vice President of Quality | 01 Şubat 2018 A | 807.591 | 0 | 0 | $0 |
| Bill Facteau | Yönetim kurulu üyesi | 06 Temmuz 2026 A | 13.123 | 0 | 0 | $0 |
| Marvin Slosman | Yönetim kurulu üyesi | 06 Temmuz 2026 A | · | 0 | 0 | $0 |
| Blank Andrew Scott | Yönetim kurulu üyesi | 06 Temmuz 2026 A | 634.023 | 0 | 0 | $0 |
| Jim L. Allen | Yönetim kurulu üyesi | 06 Temmuz 2026 A | 109.661 | 0 | 0 | $0 |
| Jay M Moyes | Yönetim kurulu üyesi | 06 Temmuz 2026 A | 54.267 | 0 | 0 | $0 |
| STERTZER SIMON H | Yönetim kurulu üyesi | 06 Temmuz 2026 A | 166.338 | 2 | 0 | $103.584 |
| Richard M Krasno | Yönetim kurulu üyesi | 23 Nisan 2025 P | 16.268 | 0 | 0 | $0 |
| Krisztina M Zsebo | Yönetim kurulu üyesi | 14 Nisan 2022 A | 2.980 | 0 | 0 | $0 |
| Richard C Pfenniger JR | Yönetim kurulu üyesi | 31 Aralık 2020 A | 51.970 | 0 | 0 | $0 |
| Fernando L Fernandez | Yönetim kurulu üyesi | 30 Eylül 2020 A | 40.644 | 0 | 0 | $0 |
| Thomas Quertermous | Yönetim kurulu üyesi | 26 Temmuz 2019 M | 15.681 | 0 | 0 | $0 |
| TESSLER ALLAN R | Yönetim kurulu üyesi | 26 Temmuz 2019 M | 23.186 | 0 | 0 | $0 |
| Stephen H Liu | Yönetim kurulu üyesi | 11 Ağustos 2016 A | 75.000 | 0 | 0 | $0 |
| Subbarao V Uppaluri | Yönetim kurulu üyesi | 11 Ağustos 2016 A | 471.592 | 0 | 0 | $0 |
| Ronald N. Richards | Yönetim kurulu üyesi | 10 Mayıs 2016 S | 0 | 0 | 0 | $0 |
| Thomas H. Morgan | Yönetim kurulu üyesi | 10 Mayıs 2016 S | 40.419 | 0 | 0 | $0 |
| Jonathan Brooks | Yönetim kurulu üyesi | 10 Mayıs 2016 S | 91.000 | 0 | 0 | $0 |
| Mikhail Kvitnitsky | 10% sahip | 01 Temmuz 2011 S | 0 | 0 | 0 | $0 |
| Steven Jerry Glauser | · | 29 Ağustos 2008 J | 7.865.768 | 0 | 0 | $0 |
| Kenneth W Good | · | 26 Eylül 2007 S | 0 | 0 | 0 | $0 |
| Willem F Specht | · | 26 Eylül 2007 S | 0 | 0 | 0 | $0 |
| Rheaume Patricia A Giuliani | · | 26 Eylül 2007 S | 0 | 0 | 0 | $0 |
| Robert M Silverson JR | · | 30 Haziran 2004 A | · | 0 | 0 | $0 |
| Anthony J Mercorella | · | 30 Haziran 2004 A | · | 0 | 0 | $0 |
| Correy J Gottlieb | · | 30 Haziran 2004 A | · | 0 | 0 | $0 |
| Randy Gerstenblatt | · | 30 Haziran 2004 A | · | 0 | 0 | $0 |
| Kenneth G Geraghty | · | 30 Haziran 2004 A | · | 0 | 0 | $0 |
| Alan Littman | · | 04 Haziran 2004 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 2 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
BCDA Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 8 analist
AL
Medyan hedef
$15.50
+1390,4%
2 25,0%
Güçlü Al
5 62,5%
Al
1 12,5%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
2 analist · 2026-09-30Ortalama hedef $15.50 +1390,4%
← Tüm hedeflerin altında
Mevcut fiyat $1.04
Düşük$6.00
Ortalama$15.50
Yüksek$25.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 12, 2026